Results for tag: "Lipid Nanoparticles"

Lipid Nanoparticles (LNPs) are a type of nanotechnology used to deliver drugs, vaccines, and other therapeutic agents to target cells. LNPs are composed of a lipid bilayer, which encapsulates the therapeutic agent, and a stabilizing agent, which helps to protect the therapeutic agent from degradation. LNPs are designed to be biocompatible and biodegradable, allowing them to be safely administered to the body. They are also designed to be able to target specific cells, allowing for more efficient delivery of the therapeutic agent. LNPs have been used in a variety of applications, including cancer therapy, gene therapy, and vaccine delivery. They have also been used to deliver imaging agents, such as contrast agents, for medical imaging. Some companies in the Lipid Nanoparticle market include Avanti Polar Lipids, Inc., NanoBio Corporation, and NanoCarrier Co., Ltd. Show Less Read more